Considering tumor-associated endothelial cells (ECs) as a major source for IL-6 expression in GBM21, we utilized a tamoxifen-inducible, EC-specific gene-knockout system to precisely regulate IL-6 expression in the tumor microenvironment. This evidence concerns the gene IL6 and neoplasm.